Gmika 250mg Injection
Marketer
Gat Pharmaceutical Private Limited
Salt Composition
Amikacin (250mg)
Overview Gmika 250mg Injection
Infectabac 250mg Injection, an antibiotic medication, combats a broad spectrum of bacterial infections. These can affect various body areas, such as the urinary system, skeletal system, respiratory system (pneumonia, for example), central nervous system, and circulatory system. Prophylactic use in hospitalized patients is also common. Infectabac 250mg Injection inhibits bacterial growth. Administered intravenously or intramuscularly by a healthcare professional, self-injection is strictly prohibited. Adherence to the prescribed dosage schedule, with evenly spaced intervals, is crucial. Complete the entire course, regardless of symptom improvement, to prevent relapse. Premature cessation can worsen or recur the infection. Typical side effects include injection site irritation and elevated blood urea nitrogen. Persistent symptoms or treatment inefficacy necessitate medical consultation. High doses may rarely cause vertigo, nephrotoxicity, and ototoxicity. Strict adherence to physician instructions is mandatory, including potential monitoring through kidney function, hearing, and urine analyses. This medication is contraindicated during pregnancy; disclose pregnancy, pregnancy plans, or breastfeeding to your physician.
Primary Ingredients of Gmika 250mg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Gmika 250mg Injection
Infections caused by bacteria
Major Benefits of Gmika 250mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Gmika 250mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Gmika 250mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Gmika 250mg Injection works:
Gamik 250mg Injection, an antibacterial medication, inhibits bacterial proliferation by disrupting the production of crucial proteins necessary for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
Gmika 250mg Injection can be taken with alcohol without adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Administering Gmika 250mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might deem its use justifiable if the potential advantages outweigh the known hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Gmika 250mg presents a low risk to breastfeeding infants. Research in humans indicates minimal transfer of the drug into breast milk, posing no discernible threat to the nursing child.
DrivingUNSAFE
Administering Gmika 250mg Injection might cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
For individuals with impaired kidney function, administering Gmika 250mg Injection requires careful consideration. A modified dosage of Gmika 250mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Gmika 250mg Injection in patients with liver impairment appears to pose minimal risk. Existing evidence indicates that dose modification may not be necessary. However, physician consultation is recommended.
What if you forget to take Gmika 250mg Injection :
Should you forget a scheduled dose of Gmika 250mg Injection, seek your physician's advice.
Facts to Know About Gmika 250mg Injection
| Label | Value |
|---|---|
| Chemical Category | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Action Class | Aminoglycoside antibiotics |
3,018 People bought this recently